CA2507714A1 - Expression vector, methods for the production of heterologous gene products and for the selection of recombinant cells producing high levels of such products - Google Patents
Expression vector, methods for the production of heterologous gene products and for the selection of recombinant cells producing high levels of such products Download PDFInfo
- Publication number
- CA2507714A1 CA2507714A1 CA002507714A CA2507714A CA2507714A1 CA 2507714 A1 CA2507714 A1 CA 2507714A1 CA 002507714 A CA002507714 A CA 002507714A CA 2507714 A CA2507714 A CA 2507714A CA 2507714 A1 CA2507714 A1 CA 2507714A1
- Authority
- CA
- Canada
- Prior art keywords
- gene
- protein
- cells
- expression
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/65—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
- C12N15/69—Increasing the copy number of the vector
Landscapes
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10256083A DE10256083A1 (de) | 2002-11-29 | 2002-11-29 | Expressionsvektor, Verfahren zur Herstellung von heterologen Genprodukten und Selektionsverfahren für hochproduzierende rekombinante Zellen |
DE10256083.8 | 2002-11-29 | ||
PCT/EP2003/013225 WO2004050879A1 (de) | 2002-11-29 | 2003-11-25 | Expressionsvektor, verfahren zur herstellung von heterologen genprodukten und selektionsverfahren für hochproduzierende rekombinante zellen |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2507714A1 true CA2507714A1 (en) | 2004-06-17 |
Family
ID=32403676
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002507714A Abandoned CA2507714A1 (en) | 2002-11-29 | 2003-11-25 | Expression vector, methods for the production of heterologous gene products and for the selection of recombinant cells producing high levels of such products |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1567648A1 (es) |
JP (1) | JP2006507829A (es) |
KR (1) | KR100820035B1 (es) |
CN (1) | CN1717486A (es) |
AR (1) | AR042244A1 (es) |
AU (1) | AU2003292102A1 (es) |
BR (1) | BR0316510A (es) |
CA (1) | CA2507714A1 (es) |
DE (1) | DE10256083A1 (es) |
MX (1) | MXPA05005482A (es) |
TW (1) | TWI321152B (es) |
WO (1) | WO2004050879A1 (es) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9045776B2 (en) | 2006-07-26 | 2015-06-02 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Regulatory nucleic acid elements |
US9534226B2 (en) | 2009-02-27 | 2017-01-03 | Novartis Ag | Expression vector system comprising two selection markers |
US11807855B2 (en) | 2013-07-31 | 2023-11-07 | Novartis Ag | Selection vectors and methods of selecting eukaryotic host cells |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT2227546T (pt) | 2007-12-21 | 2016-08-12 | Novartis Ag | Vector de expressão em mamíferos |
KR101239495B1 (ko) * | 2011-01-21 | 2013-03-05 | 경상대학교산학협력단 | αΑ-크리스탈린 유전자를 발현하는 재조합 아데노바이러스 및 이를 이용한 망막혈관 질환의 유전자 치료 |
CN103562386A (zh) * | 2011-05-25 | 2014-02-05 | 国立大学法人冈山大学 | Reic表达腺病毒载体 |
FR2981946B1 (fr) * | 2011-10-28 | 2015-02-20 | Lfb Biotechnologies | Unites de transcription et leur utilisation dans des vecteurs d'expression (yb2/0) |
CN104404072B (zh) * | 2014-11-24 | 2018-04-27 | 浙江大学 | 用标记基因预测外源基因表达量及筛选转基因家蚕的方法 |
CN106442685B (zh) * | 2016-10-25 | 2019-03-26 | 山东大学 | 一种快速低成本筛选蛋白质表达条件的方法 |
CN112424339A (zh) * | 2018-07-13 | 2021-02-26 | 隆萨有限公司 | 用于通过降低内源性蛋白质的水平来改善生物产物的生产的方法 |
WO2020227206A1 (en) * | 2019-05-07 | 2020-11-12 | Amgen Inc. | Vectors and expression systems for producing recombinant proteins |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5179017A (en) * | 1980-02-25 | 1993-01-12 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
US4656134A (en) * | 1982-01-11 | 1987-04-07 | Board Of Trustees Of Leland Stanford Jr. University | Gene amplification in eukaryotic cells |
EP0173552B1 (en) | 1984-08-24 | 1991-10-09 | The Upjohn Company | Recombinant dna compounds and the expression of polypeptides such as tpa |
ATE400651T1 (de) * | 1993-09-10 | 2008-07-15 | Univ Columbia | Verwendung von grünem fluoreszenzprotein |
US5491084A (en) * | 1993-09-10 | 1996-02-13 | The Trustees Of Columbia University In The City Of New York | Uses of green-fluorescent protein |
DE19539493A1 (de) * | 1995-10-24 | 1997-04-30 | Thomae Gmbh Dr K | Starker homologer Promotor aus Hamster |
EP0961830A1 (en) * | 1997-01-29 | 1999-12-08 | Neurosearch A/S | EXPRESSION VECTORS AND METHODS FOR $i(IN VIVO) EXPRESSION OF THERAPEUTIC POLYPEPTIDES |
ATE317011T1 (de) * | 1999-07-12 | 2006-02-15 | Genentech Inc | Expressionsvektoren und anwendungsmethoden |
EP1258255A1 (en) * | 2001-05-18 | 2002-11-20 | Boehringer Ingelheim International GmbH | Conjugates of an antibody to CD44 and a maytansinoid |
-
2002
- 2002-11-29 DE DE10256083A patent/DE10256083A1/de not_active Ceased
-
2003
- 2003-11-25 CA CA002507714A patent/CA2507714A1/en not_active Abandoned
- 2003-11-25 EP EP03767642A patent/EP1567648A1/de not_active Withdrawn
- 2003-11-25 JP JP2004556182A patent/JP2006507829A/ja active Pending
- 2003-11-25 AU AU2003292102A patent/AU2003292102A1/en not_active Abandoned
- 2003-11-25 MX MXPA05005482A patent/MXPA05005482A/es not_active Application Discontinuation
- 2003-11-25 KR KR1020057009693A patent/KR100820035B1/ko not_active IP Right Cessation
- 2003-11-25 CN CNA2003801044261A patent/CN1717486A/zh active Pending
- 2003-11-25 WO PCT/EP2003/013225 patent/WO2004050879A1/de active Application Filing
- 2003-11-25 BR BR0316510-8A patent/BR0316510A/pt not_active Expired - Fee Related
- 2003-11-26 TW TW092133164A patent/TWI321152B/zh not_active IP Right Cessation
- 2003-11-28 AR ARP030104395A patent/AR042244A1/es unknown
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9045776B2 (en) | 2006-07-26 | 2015-06-02 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Regulatory nucleic acid elements |
US9708626B2 (en) | 2006-07-26 | 2017-07-18 | Boehringer Ingelheim International Gmbh | Regulatory nucleic acid elements |
US9534226B2 (en) | 2009-02-27 | 2017-01-03 | Novartis Ag | Expression vector system comprising two selection markers |
US9994866B2 (en) | 2009-02-27 | 2018-06-12 | Novartis Ag | Expression vector system comprising two selection markers |
US11174494B2 (en) | 2009-02-27 | 2021-11-16 | Novartis Ag | Expression vector system comprising two selection markers |
US11807855B2 (en) | 2013-07-31 | 2023-11-07 | Novartis Ag | Selection vectors and methods of selecting eukaryotic host cells |
Also Published As
Publication number | Publication date |
---|---|
EP1567648A1 (de) | 2005-08-31 |
KR20050085203A (ko) | 2005-08-29 |
CN1717486A (zh) | 2006-01-04 |
JP2006507829A (ja) | 2006-03-09 |
AU2003292102A1 (en) | 2004-06-23 |
WO2004050879A1 (de) | 2004-06-17 |
KR100820035B1 (ko) | 2008-04-10 |
TWI321152B (en) | 2010-03-01 |
TW200502388A (en) | 2005-01-16 |
DE10256083A1 (de) | 2004-08-12 |
MXPA05005482A (es) | 2005-07-25 |
AR042244A1 (es) | 2005-06-15 |
BR0316510A (pt) | 2005-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003302689B2 (en) | Novel neomycin phosphotransferase genes and method for the selection of high-producing recombinant cells | |
US20090162900A1 (en) | Expression vector, methods for the production of heterologous gene products and for the selection of recombinant cells producing high levels of such of such products | |
US8338179B2 (en) | Neomycin-phosphotransferase-genes and methods for the selection of recombinant cells producing high levels of a desired gene product | |
US9708626B2 (en) | Regulatory nucleic acid elements | |
AU2009273239B2 (en) | Novel regulatory elements | |
CA2507714A1 (en) | Expression vector, methods for the production of heterologous gene products and for the selection of recombinant cells producing high levels of such products | |
NZ540950A (en) | Expression vector, methods for the production of heterologous gene products, and selection method for high-producing recombinant cells | |
CA2706873C (en) | Modified neomycin-phosphotransferase gene that increases expression rates of co-integrated gene and uses thereof | |
NZ540851A (en) | Novel neomycin phosphotransferase genes and method for the selection of high-producing recombinant cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |
Effective date: 20121126 |